A method using a liquid chromatographic-electrospray-mass spectrometric assay for the determination of antimigraine compounds: preliminary pharmacokinetics of MDL 74,721, sumatriptan and naratriptan, in rabbit
Authors:
- M.A PettyMPM.A Petty
- J SchounJSJ Schoun
- M DavidMDM David
- N.D HuebertNHN.D Huebert
- 1 April 1997
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 15 (7) , 1009-1020
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The development and cross-validation of methods based on radioimmunoassay and LC/MS-MS for the quantification of the Class III antiarrhythmic agent, MK-0499, in human plasma and urineJournal of Pharmaceutical and Biomedical Analysis, 1995
- SumatriptanDrugs, 1994
- Determination of sumatriptan succinate in plasma and urine by high-performance liquid chromatography with electrochemical detectionJournal of Pharmaceutical Sciences, 1993
- Mode of action of the anti-migraine drug sumatriptanTrends in Pharmacological Sciences, 1991
- Preclinical Studies on the Anti-Migraine Drug, SumatriptanEuropean Neurology, 1991
- Optimization and application of particle beam high-performance liquid chromatography/mass spectrometry to compounds of pharmaceutical interestJournal of Mass Spectrometry, 1990
- Migraine With and Without Aura: The Same Disease Due to Cerebral Vasospasm of Different Intensity. A hypothesis based on CBF studies during migraine.Headache: The Journal of Head and Face Pain, 1990
- Optimization and application of thermospray high-performance liquid chromatography/mass spectrometryAnalytical Chemistry, 1985
- Electrospray interface for liquid chromatographs and mass spectrometersAnalytical Chemistry, 1985
- Monodisperse aerosol generation interface for combining liquid chromatography with mass spectroscopyAnalytical Chemistry, 1984